Insider · CIK 0001335659

Krieg Arthur M

Reports to the SEC for 3 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001335659

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-06-18	Checkmate Pharmaceuticals, Inc.P Purchase	Chief Scientific Officer	PPurchase	+7,224 sh	$6.04	+$43.6K	815,734
2021-06-16	Checkmate Pharmaceuticals, Inc.P Purchase	Chief Scientific Officer	PPurchase	+3,578 sh	$6.18	+$22.1K	808,510
2021-05-28	Checkmate Pharmaceuticals, Inc.J Other	Chief Scientific Officer	JOther	−68.5K sh	—	—	0
2021-05-28	Checkmate Pharmaceuticals, Inc.J Other	Chief Scientific Officer	JOther	−68.5K sh	—	—	0
2021-05-28	Checkmate Pharmaceuticals, Inc.J Other	Chief Scientific Officer	JOther	−68.5K sh	—	—	0
2021-05-18	Checkmate Pharmaceuticals, Inc.P Purchase	Chief Scientific Officer	PPurchase	+25K sh	$6.97	+$174K	804,932
2021-03-29	Checkmate Pharmaceuticals, Inc.P Purchase	Chief Scientific Officer	PPurchase	+15.8K sh	$11.40	+$180K	779,931
2021-03-29	Checkmate Pharmaceuticals, Inc.P Purchase	Chief Scientific Officer	PPurchase	+17.5K sh	$10.94	+$191K	764,179
2021-03-26	Checkmate Pharmaceuticals, Inc.P Purchase	Chief Scientific Officer	PPurchase	+3,484 sh	$12.15	+$42.3K	746,711
2021-03-25	Checkmate Pharmaceuticals, Inc.P Purchase	Chief Scientific Officer	PPurchase	+10K sh	$12.35	+$124K	743,227
2021-01-27	Checkmate Pharmaceuticals, Inc.P Purchase	Chief Scientific Officer	PPurchase	+1,701 sh	$13.05	+$22.2K	733,191
2021-01-19	Checkmate Pharmaceuticals, Inc.P Purchase	Chief Scientific Officer	PPurchase	+500 sh	$13.09	+$6,545	731,490
2020-12-29	Checkmate Pharmaceuticals, Inc.P Purchase	Chief Scientific Officer	PPurchase	+443 sh	$14.16	+$6,272.88	730,990
2020-12-22	Checkmate Pharmaceuticals, Inc.P Purchase	Chief Scientific Officer	PPurchase	+5,103 sh	$14.64	+$74.7K	730,547
2020-12-16	Checkmate Pharmaceuticals, Inc.P Purchase	Chief Scientific Officer	PPurchase	+4,805 sh	$14.62	+$70.2K	725,444
2020-12-15	Checkmate Pharmaceuticals, Inc.P Purchase	Chief Scientific Officer	PPurchase	+42 sh	$14.49	+$608.58	720,639
2014-01-13	SRPTSarepta Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	SVP, Chief Scientific Officer	AAward	+275K sh	—	—	275,000
2007-09-18	Coley Pharmaceutical Group, Inc.Stock Options (right to buy)A Award	SVP, R & D, Chief Scien. Off.	AAward	+55K sh	—	—	55,000
2007-08-29	Coley Pharmaceutical Group, Inc.S Sale	SVP, R & D, Chief Scien. Off.	SSale	−21.1K sh	$1.89	−$39.8K	545,602
2007-02-16	Coley Pharmaceutical Group, Inc.Stock Options (right to buy)A Award	SVP, R & D, Chief Scien. Off.	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Jun 214
Krieg Arthur M0000899243-21-024984
SEC(opens sec.gov)
Jun 174
Krieg Arthur M0000899243-21-024427
SEC(opens sec.gov)
Jun 14
Krieg Arthur M0000899243-21-021392
SEC(opens sec.gov)
May 194
Krieg Arthur M0000899243-21-019922
SEC(opens sec.gov)
Mar 314
Krieg Arthur M0000899243-21-014278
SEC(opens sec.gov)
Mar 294
Krieg Arthur M0000899243-21-013801
SEC(opens sec.gov)
Jan 284
Krieg Arthur M0000899243-21-003613
SEC(opens sec.gov)
Jan 214
Krieg Arthur M0000899243-21-002720
SEC(opens sec.gov)
Dec 314
Krieg Arthur M0000899243-20-035557
SEC(opens sec.gov)
Dec 234
Krieg Arthur M0000899243-20-034982
SEC(opens sec.gov)
Dec 174
Krieg Arthur M0000899243-20-034308
SEC(opens sec.gov)
Jan 154
Sarepta Therapeutics, Inc.0001181431-14-002576
SEC(opens sec.gov)
Sep 204
Coley Pharmaceutical Group, Inc.0001181431-07-058295
SEC(opens sec.gov)
Aug 294
Coley Pharmaceutical Group, Inc.0001181431-07-054816
SEC(opens sec.gov)
Feb 214
Coley Pharmaceutical Group, Inc.0001181431-07-013054
SEC(opens sec.gov)

Companies

Address

215 FIRST STREET SUITE 7

CAMBRIDGE, MA, 02412